ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

ACCC Joins ONS In Opposing RCT Caregiver Category

March 31, 1989

Annual Report Key Element In Prevention Drive, Maquire Insists

February 2, 1979

Center Core Grants Could Face Cuts Of Up To 20%

February 16, 1990

Report Questions Effectiveness Of Bimanual Pelvic Exam

March 31, 2006

Presidents’ FY93 Budget Holds NCI To $2 Billion, Gives NIH 5% Increase; Coalition ‘Disapionted’

February 7, 1992

In Brief: Voters Support Increase In Research Funds, Poll Finds; Baynes Heads BMT Unit In Detroit

February 28, 1997